SI
Sigyn Therapeutics, Inc.
SIGY · OTC
$0.03 -2.79% (-$0.00)
1M +16.00%
Market Cap $57.8K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.04
14.9% upside
Current Price
$0.035
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SIGY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 7,197.69%
Asset turnover 0.00x
ROIC 37.61%
Debt
0 /100
High Int. coverage -3.98x
Current ratio 0.00x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 2,404.83%
Profitable years 0
Beta -0.06x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SIGY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James A. Joyce
Employees
4
Headquarters
San Diego
Upcoming events
18 NOV
Earnings
Upcoming earnings report